| Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Outline of Final Research Achievements |
We developed an evaluation method for the physical activity of patients with COPD by using a triaxial accelerometer, Actimarker, which is available in Japan. The duration of physical activity in patients with COPD was significantly reduced at any intensity of activity, and that at greater than or equal to 3.0METs was reduced by 50% compared to that of age-matched healthy subjects. Transdermal tulobuterol, a beta-2 adrenergic agonist, could improve the physical activity, especially at high intensity. There is a flying disc accuracy game with low intensity of activity that is feasible for patients and sufficiently enjoyable that they were motivated to participate repeatedly. Participation in such a game might be an effective intervention to maintain or improve the physical activity of patients with COPD.
|
